We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs, Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Daily Bulletin
    • Drug Industry Daily
  • Device News
    • Trending
    • Commercial Operations
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Daily Bulletin
    • FDAnews Device Daily Bulletin Premium
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » Devices

Devices
Devices RSS Feed RSS

FDA Deems Cardiosave Intra-Aortic Balloon Recall Class I

March 21, 2023

The potential issue affects units distributed before July 24, 2017. 

Read More

Aspivix Cervical Stabilizer Study Shows Reduced Pain and Bleeding

March 20, 2023

Pain and bleeding were reduced in a clinical trial testing Aspivix’s Carevix cervical stabilizer device against a standard tenaculum — used to stabilize the cervix to ease passage of instruments — among women undergoing intrauterine device (IUD) placement to prevent pregnancy.

Read More

FDA Raps North Carolina Facility for CAPA Issues, Lax MDR Procedures

March 20, 2023

North Carolina-based Carolina Biological Supply was handed a Form 483 for lacking adequate procedures for corrective and preventative actions (CAPA), medical device reporting (MDR) and audits, among other lapses. 

Read More

Companies Need an SOP for Inspections, Expert Says

March 20, 2023

Having operational logistics in place for your FDA inspection means writing down the inspection plan beforehand in a standard operating procedure (SOP), starting with the moment the investigators walk in the door, advised inspection expert David Chesney, principal of DL Chesney Consulting, in a recent WCG FDAnews webinar.

Read More

ICER Aims to Consider Health Equity in Its Product Value Assessments

March 20, 2023

ICER plans to release an update of its Value Assessment Framework later this year.

Read More

BD’s COR System Cleared for Detecting Three Causes of Vaginitis

March 20, 2023

Four out of 10 women don’t receive the appropriate diagnosis and treatment for their vaginitis symptoms after an initial physician visit, which leads to additional visits because of persistent symptoms, the company said. 

Read More

Cotras Gets FDA Approval of Virtual Reality Rehab Device

March 20, 2023

The device supports aging-in-place by enabling patients to regain mobility and function.

Read More

Device Labeling Must Include Any New Intended Uses

March 17, 2023

Among the many requirements to bring your product to market is to have accurate labeling — as well as procedures in place to ensure that and any new intended uses are included.

Read More

Illinois Device Facility Dinged for Design Control, CAPA and Complaint Issues

March 17, 2023

The FDA handed Oak Ridge Products a Form 483 for a lack of design control documents as well as inadequate corrective and preventive action (CAPA) procedures and complaint handling, among other lapses.

Read More

ICER Aims to Consider Health Equity in Its Product Value Assessments

March 17, 2023

The Institute for Clinical and Economic Review (ICER) plans to take health equity into account in its product value assessments and has come up with some ideas for how to do that.

Read More

Visby Medical STI Test gets FDA Clearance

March 17, 2023

The test can be used in CLIA-waived point-of-care settings.

Read More

TytoCare AI Home Wheeze Detection Device gets FDA Clearance

March 17, 2023

The decision support software previously gained CE mark certification.

Read More
Previous 1 2 3 4 5 6 7 8 9 … 1041 1042 Next

Upcoming Events

  • 04Apr

    Optimizing Quality Control Operations with Unified Quality

  • 20Apr

    Medical Device Enforcement: Latest Developments from the FDA, DOJ and FTC

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • Advamedica’s Hemostat Cleared for Severe Surgical Bleeding

  • FDA Approves Sandoz’s Citrate-Free Adalimubab Formulation

  • Wesper Next-Generation Device Cleared for Sleep Test Data Collection

  • FDA Approves First-Ever Treatment for Activated Phosphoinositide 3-Kinase Delta Syndrome

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing